Orthofix Medical (FRA:OM2) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OM2 Orthofix Medical Inc FRA:OM2
60 GF Score
Price €8.70
GF Value €12.11
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Orthofix Medical Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Orthofix Medical Quality Rank Related Terms

FRA:OM2
60GF Score
Orthofix Medical Inc FRA:OM2
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Orthofix Medical (FRA:OM2) Overvalued in 2026?

Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued. The current stock price of €8.70 is trading 28.2% below its estimated GF Value™ of €12.11. GuruFocus considers Orthofix Medical to be Modestly Undervalued.

Key valuation signals for FRA:OM2:

  • Quality Rank:
  • GF Value™: €12.11 vs. price of €8.70 (28.2% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the FRA:OM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orthofix Medical Business Description

Other Exchanges OFIX:USA
Address 3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
60GF Score

Get the complete analysis for FRA:OM2

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.70
Price
€12.11
GF Value